deltatrials

University Hospital, Rouen Clinical Trials

Sponsors / University Hospital, Rouen

346 ClinicalTrials.gov entries name University Hospital, Rouen as the lead sponsor. The portfolio currently includes 60 recruiting studies, 5 active non-recruiting studies, and 200 completed studies. 38 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, safety concerns. Cumulative planned enrollment across all listed trials is 77,621 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.

346
Total Trials
60
Recruiting
5
Other Active
200
Completed
38
Terminated / Withdrawn
77,621
Total Enrollment

Termination reasons: Other53% · Recruitment39% · Safety5% · PI/or_Site3%

Recent Terminations

  • NCT04643535 Stopped Dec 2025
    Cardiovascular Diseases
    "The period of authorization for effective inclusion has ended at 130 inclusions out of a theoretical 600."
  • NCT04820075 Phase NA Stopped Jul 2025
    Surgery
    "impossible to continue the study"
  • NCT05326646 Phase NA Stopped Feb 2024
    Irritable Bowel Syndrome
    "The Medical Device (SmartPill) used in this project is no longer on the market"
  • NCT04456868 Phase NA Stopped Aug 2023
    Bipolar Anhedonic Depression
    "Inability to include additional patients in the arms with depression"
  • NCT04720261 Phase PHASE2 Stopped May 2023
    Thrombotic Thrombocytopenic Purpura, Acquired
    "Recommendations of the independent oversight committee."
  • NCT05401617 Stopped Oct 2022
    Pediatric Surgery
    "Difficulty in enrolling new patients"
  • NCT04707833 Stopped Dec 2021
    Corona Virus Infection
    "The inclusion and exclusion criteria have become very restrictive, resulting in a very limited eligible population"
  • NCT04131660 Stopped Jun 2021
    Acute Respiratory Failure
    "Difficulty in enrolling new patients"
  • NCT04730661 Phase NA Stopped Jun 2021
    SARS-CoV Infection
    "decrease of inclusion capacities because of the control of COVID 19 epidemia thanks to vaccination"
  • NCT04710914 Phase PHASE4 Stopped Dec 2020
    Septic Shock
    "COVID epidemic and sedation practices that have completely changed: the standard sedative is now propofol rather than midazolam."

Active Trials (5 total)

Top Conditions

Top Locations